Speakers:

Joseph P. McConnell, PhD
Chief Medical Officer, Laboratory Director, Co-Founder -- Health Diagnostic Laboratory, Inc.
Assistant Professor of Laboratory Med/Pathology -- College of Medicine, Mayo Clinic
Kevin C. Maki, PhD
President & Chief Science Officer, Provident Clinical Research, a Division of Provident Clinical Research & Consulting, Inc.

Learning Objectives:

After participating in this workshop, participants will be able to:

1. Explain how Non-HDL Cholesterol reflects CVD risk.
2. Review prominence of Non-HDL Cholesterol in the national cholesterol treatment guidelines and the use of Non-HDL Cholesterol as target for patient treatment.
3. Compare and contrast utilization of non-HDL-C with alternative lipid and lipoprotein markers such as Apolipoprotein B and LDL particle concentration.
4. Describe how clinical laboratories can routinely report Non-HDL Cholesterol with routine lipid results.